pazopanib
UkraineDrugs containing this active substance
-
The drug is used for the treatment of advanced or metastatic renal cell carcinoma, as well as for patients with advanced soft tissue sarcoma who have previously undergone chemotherapy (with the exception of certain tumor types, such as liposarcoma).
Form: tablets, film-coated
Active substance Dosage pazopanib 200 mg ATC: L01EX03
Manufacturer: Faros MT Limited
-
The drug is used for the treatment of advanced or metastatic renal cell carcinoma, as well as for patients with advanced soft tissue sarcoma who have previously undergone chemotherapy (with the exception of certain tumor types, such as liposarcoma).
Form: tablets, film-coated
Active substance Dosage pazopanib 400 mg ATC: L01EX03
Manufacturer: Faros MT Limited
-
The drug is used for the treatment of locally advanced and/or metastatic renal cell carcinoma, as well as for the treatment of patients with advanced soft tissue sarcoma who have previously undergone chemotherapy (with the exception of certain tumor types, such as liposarcoma or gastrointestinal stromal tumor).
Form: tablets, film-coated
Active substance Dosage pazopanib 400 mg ATC: L01EX03
Manufacturer: Glaxo Operations UK Limited (manufacturer of unpackaged products)
-
The drug is prescribed for the treatment of advanced and/or metastatic renal cell carcinoma, as well as for the treatment of patients with advanced soft tissue sarcoma who have previously received chemotherapy (except for patients with gastrointestinal stromal tumor or liposarcoma).
Form: tablets, film-coated
Active substance Dosage pazopanib 200 mg ATC: L01EX03
Manufacturer: Glaxo Operations UK Limited (manufacturer of unpackaged products)